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During angiogenesis in vivo, endothelial cells (ECs) at
the tips of vascular sprouts actively extend filopodia
that are filled with bundles of linear actin filaments.
To date, signaling pathways involved in the formation
of endothelial filopodia have been studied using in-
vitro-cultured ECs that behave differently from those
in vivo. Herein, we have delineated a signaling
pathway that governs the assembly of endothelial
filopodia during angiogenic sprouting of the caudal
vein plexus (CVP) in zebrafish. During CVP forma-
tion, bone morphogenetic protein induces the exten-
sion of endothelial filopodia and their migration
via Arhgef9b-mediated activation of Cdc42. Active
Cdc42 binds to and stimulates Formin-like 3, an
actin-regulatory protein of the formin family, which,
in turn, promotes the extension of endothelial filopo-
dia to facilitate angiogenic sprouting of the CVP.
Thus, this study has elucidated molecular mecha-
nisms underlying the formation of endothelial filopo-
dia and their role in angiogenesis in vivo.
INTRODUCTION
Angiogenesis refers to the physiological and pathological pro-
cesses through which new blood vessels form from pre-existing
ones. During in vivo angiogenesis, endothelial tip cells at the
fronts of the growing vessels actively extend filopodia in the di-
rection of cell migration in response to guidance cues (Gerhardt
et al., 2003; De Smet et al., 2009). Filopodia are thin, finger-like
protrusions that are filled with tight parallel bundles of filamen-
tous actin (F-actin) and function as antennae allowing cells to
probe their microenvironment (Mellor, 2010; Mattila and Lappa-
lainen, 2008). Consequently, filopodia play an important role in
numerous cellular processes, including cell migration, wound
healing, cell adhesion to the extracellular matrix, chemotactic
axon guidance, and embryonic development (De Smet et al.,
2009; Mattila and Lappalainen, 2008; Mellor, 2010). Therefore,Developmit is believed that filopodia on endothelial tip cells lead the way
for vessel growth by sensing guidance cues during angiogen-
esis. However, this notion was challenged by a recent study
showing that inhibition of the formation of filopodia did not affect
guided migration of endothelial cells (ECs) but did decrease their
migration velocity during angiogenesis (Phng et al., 2013). These
results imply that filopodia are required for efficient EC migration
during angiogenesis but are not necessary for endothelial tip cell
guidance. Therefore, the mechanisms by which EC filopodia
regulate angiogenesis in vivo remain unknown.
The Rho family small GTPases regulate actin cytoskeleton
reorganization, thereby controlling cell morphology and motility
(Heasman and Ridley, 2008). Among these proteins, Cdc42 pro-
motes the formation of filopodia, whereas RhoA and Rac1
induce the formation of stress fibers and lamellipodia, respec-
tively. Two models, convergent elongation and tip nucleation,
have been proposed to underlie the formation of filopodia (Mel-
lor, 2010; Mattila and Lappalainen, 2008). The tip nucleation
model involves filopodial actin filaments being directly nucleated
at filopodial tips by formins. Formin-family proteins promote the
assembly of linear actin filaments and are required to generate
cellular actin structures such as filopodia and stress fibers
(Higgs, 2005; Watanabe and Higashida, 2004; Yang and Svit-
kina, 2011). Among these proteins, mDia2 (also known as DI-
APH3) and Formin-like protein 3 (FMNL3, also known as FRL2)
have been shown to induce the formation of filopodia (Yang
and Svitkina, 2011; Peng et al., 2003; Harris et al., 2010).
mDia2 is autoinhibited via an intramolecular interaction between
its N- and C-terminal regions, which masks the formin homology
(FH) 1 and FH2 catalytic domains. Active Cdc42 binds to the
N-terminal GTPase binding domain (GBD) of mDia2, which pre-
vents the autoinhibitory interaction, thereby promoting the as-
sembly of linear actin filaments (Mellor, 2010; Mattila and Lappa-
lainen, 2008). However, the activation mechanism of FMNL3
remains unknown.
Rho GTPases are involved in the regulation of EC morphology
andmotility (Lamalice et al., 2007; De Smet et al., 2009). Vascular
endothelial growth factor (VEGF) regulates EC migration and
actin cytoskeleton via activation of Rac1 and Cdc42 (Soga
et al., 2001; Garrett et al., 2007; Lamalice et al., 2007). However,
our current knowledge regarding themechanism of ECmigration
is based only on the results of in vitro studies, in which ECs neverental Cell 32, 109–122, January 12, 2015 ª2015 Elsevier Inc. 109
Figure 1. Filopodia Are Required for EC Migration during CVP Formation
(A and B) 3D-rendered confocal images of the CVP of Tg(fli1:lifeact-mCherry);(fli1:Myr-GFP) embryos at 25 hpf (A) and 28 hpf (B) and their subsequent time-lapse
images at the indicated time points. Upper row: mCherry images (intensity of Lifeact-mCherry is shown as a grayscale image); lower row, mCherry/GFP ratio
images shown in the IMD mode (Ratio). The upper and lower limits of the ratio range are indicated on the right. The boxed areas labeled with numbers 1–4 are
enlarged on the right side.
(C) 3D-rendered confocal images of the CVP of Tg(fli1:lifeact-mCherry);(fli1:Myr-GFP) embryos treated with DMSO or 0.1 mg/ml Lat. A from 26 to 29 hpf. Top: ratio
images of mCherry/GFP; middle: enlarged images of the boxed areas; bottom: enlarged mCherry images of the boxed areas. The upper and lower limits of the
ratio range are indicated on the bottom.
(D) The number of filopodia for each EC located at the vascular front, as observed in (C), was quantified as described in the Experimental Procedures and shown
as the mean ± SEM (DMSO, n = 10; Lat. A, n = 12).
(legend continued on next page)
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extend long filopodia as observed in vivo. Thus, themechanisms
by which Rho GTPases regulate the extension of EC filopodia
during in vivo angiogenesis remain unknown.
Here, we used in vivo fluorescence-based bioimaging tech-
niques using zebrafish and delineated the signaling pathway
that governs the formation of EC filopodia in angiogenic sprout-
ing of the caudal vein plexus (CVP). Cdc42 is activated by bone
morphogenetic protein (Bmp) through Arhgef9b (also known as
Collybistin) and promotes Fmnl3-mediated formation of EC filo-
podia, thereby facilitating sprouting angiogenesis during CVP
formation.
RESULTS
Filopodial Formation Is Required for ECMigration during
Caudal Vein Formation
To investigate the molecular mechanisms underlying EC
morphology and motility during angiogenesis, we focused on
the morphogenic processes involving caudal veins (CVs), since
their formation occurs through sprouting angiogenesis. For
CV development, ECs must sprout from CV primordia, migrate
ventrally at approximately 27 hr postfertilization (hpf), and form
the CVP through the process of angiogenesis at 36 hpf (Fig-
ure S1A available online). To analyze actin cytoskeleton dy-
namics in ECs during angiogenesis, we have developed a double
transgenic (Tg) zebrafish line that expresses C-terminally
mCherry-tagged lifeact, a small actin-binding peptide (Riedl
et al., 2008) and myristoylation signal (Myr)-tagged GFP
under the control of the EC-specific fli1 promoter Tg(fli1:lifeact-
mCherry);(fli1:Myr-GFP) by exploiting the Tol2 transposon sys-
tem (Figures S1B and S1C). ECs on the ventral side of the CV
primordia showed repeated extension and retraction of small
and short-lived filopodia and started to migrate ventrally by pro-
ducing a single, long, thick filopodium (Figure 1A; Figure S1D;
Movie S1). During this ventral migration, the ECs led by filopodia
anastomosing with each other formed the CVP (Figure 1B;Movie
S2). Filopodia extending from migrating ECs were filled with
linear actin filaments (Figures 1A and 1B). F-actin was also de-
tected at cell-cell junctions and in the cell cortex (Figures 1A
and 1B).
We next investigated whether linear F-actin assembly and the
extension of filopodia in ECs are required for CVP formation. It
was previously reported that low concentrations of actin poly-
merization inhibitor block the formation of EC filopodia in zebra-
fish (Phng et al., 2013). Consistently, the embryos treated with
0.1 mg/ml latruncullin A (Lat. A), a toxin that prevents actin poly-
merization by binding to actin monomers (Morton et al., 2000),
exhibited disruption of linear F-actin and subsequent breakdown(E) Projection view of confocal z stack images of the CVP of Tg(flk1:NLS-Eos);(fl
merged images of Eos (green) and mCherry (red) are superimposed on the migra
from 25 to 31 hpf.
(F) The EC migration distance, as observed in (E), was quantified and is shown a
(G) Projection view of confocal z stack images of the caudal regions of Tg(fli1:GFP
left panel are enlarged in themiddle panel. The cross-sectional single-plane image
right column. CA, caudal artery.
(H) The CVP width, as observed in (G), was quantified and is shown as the mean
Scale bars, 50 mm in (E) and (G). All zebrafish images are shown dorsal to the to
Figure S1 and Movies S1, S2, and S3.
Developmof filopodia in the ECs forming the CV (Figures 1C and 1D). More-
over, ventral migration of ECs and CVP formation were inhibited
by Lat. A treatment (Figures 1E–1H; Movie S3). These results
indicate linear F-actin assembly and the subsequent formation
of filopodia to be responsible for ventral migration of ECs during
CVP formation.
Bmp Promotes EC Extension to Form Filopodia, Thereby
Regulating CVP Formation
Bmp2b promotes venous angiogenesis to form the CV through
activation of Bmp receptor type II (Bmpr2) a/b and activin recep-
tor-like kinase 2/3 (Alk2/3) heterotetrameric receptor complexes
(Wiley et al., 2011). Thus, we investigated the role of Bmp in the
formation of filopodia by EC during CVP development by exam-
ining the effect of a Bmp antagonist, Noggin3. For this purpose,
Tg(fli1:lifeact-mCherry);(fli1:Myr-GFP) embryos were injected
with heat shock protein (hsp)70l:noggin3-FLAG plasmid at the
one-cell stage and then heat shocked at 22 hpf for 2 hr. Overex-
pression of Noggin3 reduced the number of sprouts from the CV
primordia and that of filopodia extending from the ECs in the CV
primordia, thereby leading to defective CVP formation (Figures
2A–2C; Figure S2A). To clarify the role of Bmp signaling in ECs,
we analyzed Tg(fli1:Gal4FF);(fli1:Myr-mCherry) embryos injected
with a UAS:GFP,bmpr1DC-FLAG Tol2 plasmid, which drives
the expression of GFP and a dominant-negative mutant of
Bmpr1 (Bmpr1DC-FLAG) simultaneously in ECs (Figure S2B).
Bmpr1DC-FLAG-expressing ECs failed to localize on the ventral
side of the CVP, indicating that endothelial Bmp signaling is
required for ventral migration of ECs during CVP formation (Fig-
ures 2D and 2E). In contrast, Hsp-mediated overexpression of
Bmp2b induced dorsal sprouting of ECs from the CVP, leading
to the formation of ectopic venous vessels (Figure S2C; Movie
S4). In the ectopic sprouts, ECs actively produced numerous
filopodia that were filled with linear F-actin, although their cell
morphology differed from that of the ventrally migrating ECs
(Figure 2F). Lat. A disrupted filopodia in sprouting ECs and pre-
vented the formation of ectopic venous vessels (Figures 2G–2J).
These results suggest that Bmp is involved in the extension of
filopodia by EC during CVP formation.
Recently, Dunworth et al. (2014) showed that Bmp signaling
suppresses lymphatic cell fate specification through miR-31-
and miR-181a-mediated downregulation of Prox1a, a key
regulator of lymphatic EC differentiation, raising the possibility
that Bmp might induce EC to form filopodia by negatively regu-
lating lymphatic EC development. To address this possibility, we
examined the effect of Noggin3 on CVP formation in embryos
depleted of Prox1a. Overexpression of Noggin3 resulted in
the inhibition of CVP formation in both control morpholinoi1:Myr-mCherry) embryos treated with DMSO or Lat. A from 25 to 31 hpf. The
tion paths of ECs (white lines) inferred from time-lapse confocal movies taken
s the mean ± SEM (DMSO, n = 6; Lat. A, n = 6).
) embryos treated with DMSO or Lat. A from 24 to 33 hpf. The boxed areas in the
s of the areas indicated by dotted lines on the enlarged images are shown in the
± SEM (DMSO, n = 8; Lat. A, n = 8).
p and anterior to the left, unless otherwise described. ***p < 0.001. See also
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Figure 2. Bmp Induces EC to Extend into Filopodia during CVP Formation
(A) 3D-rendered confocal 3D images of the CVP of 29 hpf Tg(fli1:lifeact-mCherry);(fli1:Myr-GFP) embryos injected without (Control) or with hsp70l:noggin3-FLAG-
Tol2 plasmid and heat shocked at 22 hpf for 24 hr are shown as in Figure 1A.
(B) The total number of sprouts extending from the CV primordia, as observed in (A), was counted and is shown as the mean ± SEM (Control, n = 5;
hsp70l:noggin3-FLAG, n = 4).
(C) The number of filopodia for each EC located at the vascular front, as observed in (A), was quantified as in Figure 1D (Control, n = 5; hsp70l:noggin3-FLAG,
n = 4). Error bars indicate means ± SEM.
(D) Projection view of confocal z stack images of the caudal regions of 33 hpf Tg(fli1:Gal4FF);(fli1:Myr-mCherry) embryos injected with UAS:GFP Tol2 vector
(UAS:GFP) or UAS:GFP,bmpr1DC-FLAG Tol2 plasmid (UAS:GFP,bmpr1DC-FLAG). Left, GFP images; right, the merged images of GFP (green) and mCherry
(red). Arrows indicate GFP-expressing ECs that localize in the ventral part of CVP. CA, caudal artery; dCVP, dorsal part of CVP; vCVP, ventral part of CVP.
(E) Percentages of GFP-expressing ECs localizing in the dCVP or vCVP, as observed in (D), are shown as means ± SEM (UAS:GFP, n = 6; UAS:GFP, bmpr1DC-
FLAG, n = 5).
(F) 3D-rendered confocal images of the caudal regions of 36 hpf Tg(fli1:lifeact-mCherry);(fli1:Myr-GFP) embryos injected without (Control, left panel) or with
hsp70l:bmp2b-FLAG Tol2 plasmid (right three panels) and heat shocked at 24 hpf for 30 min are shown as in Figure 1A. The mCherry/GFP ratio and mCherry
images of the boxed area are enlarged in the third and fourth panels from the left, respectively. Arrow indicates ectopic venous vessels.
(legend continued on next page)
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oligonucleotide (MO)-injected and prox1aMO-injected embryos,
although prox1a morphants exhibited defects in thoracic duct
formation (Figures S2D–S2F). Moreover, knockdown of miR-31
andmiR-181a did not affect the formation of ectopic venous ves-
sels induced by overexpression of Bmp2a (Figures S2G and
S2H). These findings indicate that Bmp induces EC extension
of filopodia during CVP formation independently of its role in
EC fate determination.
Cdc42 Induces EC Extension of Filopodia during CVP
Formation
Among the Rho family GTPases, Cdc42 is involved in the forma-
tion of filopodia. To investigate whether Cdc42 regulates the for-
mation of filopodia by EC during sprouting angiogenesis in vivo,
we visualized the localization of active Cdc42 in ECs by analyzing
Tg(fli1:Gal4FF) embryos injected with a UAS:mCherry,GFP-N-
WASP CRIB Tol2 plasmid, which drives the expression of
mCherry and the GFP-tagged Cdc42/Rac interactive binding
domain (CRIB) of neural Wiskott-Aldrich syndrome protein
(GFP-N-WASP CRIB) simultaneously in ECs. GFP-N-WASP
CRIB, but not its mutant incapable of binding Cdc42 (GFP-N-
WASP CRIB H211D), was clearly accumulated in the filopodia,
which extended from sprouting ECs during CVP formation (Fig-
ures 3A–3D). Consistently, Cdc42 activation in EC filopodia
was also confirmed by the analyses using a fluorescence reso-
nance energy transfer (FRET)-based biosensor for Cdc42 (Fig-
ures S3A–S3E) (Komatsu et al., 2011; Ando et al., 2013). These
results indicate that Cdc42 is activated in the filopodia produced
by the sprouting ECs during CVP formation.
To investigate the role of Cdc42 in EC extension to form filopo-
dia, we analyzed embryos injected with 5 ng cdc42MO, in which
Cdc42 expression was partially downregulated (Figure S3F).
These morphants appeared morphologically normal but clearly
exhibited defects in CVP formation, which was partially normal-
ized by injecting MO-resistant cdc42mRNA (Figures 3E and 3F;
Figure S3G). Consistently, a partial depletion of Cdc42 reduced
the number of sprouts from CV primordia, as well as that of filo-
podia extending from ECs during CVP formation (Figures 3G–3I),
indicating that Cdc42 regulates EC extension to form filopodia
during CVP development. However, cdc42 morphants also ex-
hibited decreased numbers of ECs in the CVP (Figures S3H
and S3I). Therefore, Cdc42 might regulate not only EC
morphology and motility but also EC proliferation and/or survival
during CVP formation.
To confirm the role of Cdc42 in EC extension to form filopodia
during CVP development, we specifically inhibited the endothe-
lial Cdc42-dependent signal by expressing the membrane-tar-
geted form of ACK42 (Myr-GFP-ACK42) in ECs. ACK42 is a
Cdc42-specific inhibitor derived from ACK1 that specifically(G) 3D-rendered confocal images of the caudal regions of 36 hpf Tg(fli1:lifeact-mC
heat shocked at 24 hpf for 30 min and treated with DMSO or Lat. A from 29 to 3
(H) The number of filopodia for each EC located at the front of ectopic vessels, as o
bars indicate means ± SEM.
(I) Projection view of confocal z stack images of the caudal regions of 48 hpf Tg(fli1
at 24 hpf for 30 min, and treated with DMSO or Lat. A from 33 to 48 hpf. Dotted
(J) The areas covered by ectopic venous vessels as observed in (I) were quantifi
embryos. Data are shown as means ± SEM (DMSO, n = 5; Lat. A, n = 5).
Scale bars, 100 mm in (D) and (I). *p < 0.05; **p < 0.01; ***p < 0.001. See also Fig
Developmbinds to the active form of Cdc42 (Figure S3J) (Nur-E-Kamal
et al., 1999). In Tg zebrafish embryos in which Myr-GFP-
ACK42 was specifically expressed in ECs, the ECs in the CV
primordia failed to extend to form filopodia (Figures S3K and
S3L). We further examined embryos that exhibited mosaic
expression of GFP, Myr-GFP-ACK42, or GFP-tagged domi-
nant-negative mutant of Cdc42 (GFP-Cdc42 T17N) in ECs
(Figures 3J–3L; Figures S3M and S3N; Movie S5). During CVP
formation, more than 70% of ECs expressing either Myr-GFP-
ACK42 or GFP-Cdc42 T17N failed to migrate ventrally and re-
mained on the dorsal side of the CVP. Collectively, these results
indicate that Cdc42 promotes EC extension to form filopodia
and their migration to regulate CVP formation. Consistently, an
in vitro EC spheroid-sprouting assay also revealed that Cdc42
is required for EC sprouting (Figures S3O and S3P).
Bmp Regulates CVP Formation through Arhgef9b, a
Guanine Nucleotide Exchange Factor for Cdc42
Ets1-related protein (Etsrp), a transcription factor involved in
vascular development, induces the expressions of guanine
nucleotide exchange factors (GEFs) for Cdc42, including Arh-
gef9b and Fgd5 (Gomez et al., 2009). We investigated whether
these GEFs function in Cdc42-mediated extension of filopodia
during CVP formation. In situ hybridization analyses revealed
arhgef9b and fgd5 mRNAs to be exclusively expressed in
the vasculature of zebrafish embryos (Figure 4A; Figure S4A).
Most notably, arhgef9b mRNA was highly expressed in the CV
primordia and CVP of 24 and 30 hpf embryos, respectively (Fig-
ure 4A). Knockdown of Arhgef9b by MO resulted in an impair-
ment of CVP formation, whereas fgd5 morphants showed
normal CVP structures (Figures 4B and 4C; Figures S4B–S4G).
Depletion of Arhgef9b also reduced the number of sprouts
from CV primordia and that of filopodia extending from ECs
during CVP formation (Figures 4D–4F). These results suggest
Arhgef9b as a Cdc42 GEF to play a role in CVP formation.
Consistently, overexpression of GFP-tagged Arhgef9b (GFP-
Arhgef9b) in 293T cells activated Cdc42 but not RhoA or
Rac1 (Figure S4H). Furthermore, the impaired CVP formation
observed in the arhgef9bmorphants was normalized by injecting
MO-resistant mRNA encoding GFP-Arhgef9b but not by inject-
ing MO-resistant mRNA encoding the corresponding catalyti-
cally inactive mutant GFP-Arhgef9b 4A (Figures 4B and 4C;
Figure S4I). These results suggest that Arhgef9b, but not Fgd5,
activates Cdc42 to regulate CVP formation.
We next investigated whether Arhgef9b acts downstream
from Bmp to regulate CVP formation. Depletion of Arhgef9b
significantly suppressed Bmp2b-induced formation of ectopic
vessels (Figures 4G and 4H). We further determined the genetic
interaction between Bmp signaling and Arhgef9b during CVPherry);(fli1:Myr-GFP) embryos injected with hsp70l:bmp2b-FLAG Tol2 plasmid,
3 hpf are shown as in Figure 1A. Arrows indicate ectopic venous vessels.
bserved in (G), was quantified as in Figure 1D (DMSO, n = 7; Lat. A, n = 7). Error
:GFP) embryos injected with hsp70l:bmp2b-FLAG Tol2 plasmid, heat shocked
lines indicate ectopic venous vessels.
ed and expressed as percentages relative to that observed in DMSO-treated
ure S2 and Movie S4.
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Figure 3. Cdc42 Mediates EC Extension into Filopodia during CVP Formation
(A) 3D-rendered confocal images of the ECs in the CVP of 29 hpf Tg(fli1:Gal4FF) embryos injected withUAS:mCherry,GFP-N-WASPCRIB Tol2 plasmid. The GFP
image, themerged image of GFP (green) andmCherry (red) (GFP/mCherry), and the GFP/mCherry ratio image, in the IMDmode (Ratio), are shown as indicated at
(legend continued on next page)
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formation by using MOs targeting two Bmpr2 receptors (bmpr2a
and bmpr2b) and arhgef9b. Injection of a low dose of either a
combination of bmpr2a MO (1 ng) and bmpr2b MOs (0.5 ng) or
arhgef9bMO alone (0.5 ng) into zebrafish embryos did not affect
CVP formation, while a high dose of either MO (a combination of
5 ng of bmpr2a and 2.5 ng of bmpr2bMOs or 2.5 ng of ahrgef9b
MO) clearly inhibited CVP formation (Figures 4I and 4J). How-
ever, coinjection of a low dose of bmpr2a or bmpr2b MOs with
the arhgef9b MO impaired CVP formation (Figures 4I and 4J).
These findings suggest that Bmp is likely to be involved in the
regulation of Cdc42-mediated extension of filopodia and CVP
formation by Arhgef9b.
Fmnl3-Driven Actin Polymerization Is Required for EC
Extension to Form Filopodia during CVP Development
We investigated the molecular mechanism underlying Cdc42-
mediated filopodia extension during CVP formation. Filopodia
formation is believed to be driven by assembly of linear F-actin.
Among regulators of the actin cytoskeleton, formin family pro-
teins are known to regulate the formation of linear unbranched
actin (Higgs, 2005; Watanabe and Higashida, 2004; Yang and
Svitkina, 2011). Therefore, we first investigated whether formin
family proteins are involved in EC extension to form filopodia
during CVP development. Treatment with a formin inhibitor,
SMIFH2 (Rizvi et al., 2009), disrupted EC filopodia and prevented
CVP formation (Figures 5A–5D), suggesting the involvement of
formin family proteins in these processes.
In mammals, 15 members of the formin family of proteins
have been identified. To investigate which of these proteins
are involved in the formation of filopodia by ECs, we analyzed
their expressions by RT-PCR in three human EC lines (Fig-
ure S5A). Expressions of FMNL2, FMNL3, FHOD1, DIA1,
DIAPH3, and INF2 were detected in all EC lines. Among thesethe top. The boxed area in the Ratio image is enlarged on the far right side. The ins
contrast GFP and mCherry images. The upper and lower limits of the ratio range a
nucleus indicated by asterisks does not reflect localization of GTP-Cdc42, since its
H211D), was also accumulated in the nucleus as shown in (C).
(B) Relative GFP/mCherry ratio (localization of GTP-Cdc42) in the filopodia and ce
expressed as the fold increase relative to that observed in the cell body. Data ar
(C) 3D-rendered confocal images of the EC in the CVP of 29 hpf Tg(fli1:Gal4FF) em
shown as in (A).
(D) Relative GFP/mCherry ratio in the filopodia and cell bodies of ECs located at th
bars indicate means ± SEM.
(E) Projection view of confocal z stack images of the caudal regions of 33 hpf Tg(
(middle panel), and 5 ng cdc42 MO together with 100 pg MO-resistant cdc42 m
(F) The CVP width, as observed in (E), was quantified and is shown as the mean ±
(G) 3D-rendered confocal images of the CVP of 29 hpf Tg(fli1:lifeact-mCherry);(fl
cdc42 MO (lower panels) are shown as in Figure 1A.
(H) The number of sprouts extending from the CV primordia, as observed in (G), w
indicate means ± SEM.
(I) The number of filopodia for each EC located at the vascular front, as observed in
bars indicate means ± SEM.
(J) Projection view of confocal z stack images of the CVP of Tg(flk1:Gal4FF-2A-
UAS:Myr-GFP-ACK42-Tol2 plasmid at 28 hpf and subsequent time-lapse images
(red) are shown. Arrowheads and arrows indicate GFP-positive andGFP-negative
during CVP formation.
(K) Projection views of confocal z stack images of the caudal regions of 33 hpf Tg
Tol2 plasmid or UAS:Myr-GFP-ACK42 Tol2 plasmid are shown as in Figure 2D.
(L) Percentages of GFP-expressing or Myr-GFP-ACK42-expressing ECs localize
observed in (K), are shown as means ± SEM (GFP, n = 8; Myr-GFP-ACK42, n =
Scale bars, 100 mm in (E) and (K) and 50 mm in (J). **p < 0.01; ***p < 0.001; n.s.,
Developmproteins, FMNL3 has been shown to regulate angiogenesis,
although its role in actin cytoskeleton regulation in ECs has
not been studied (Hetheridge et al., 2012). Thus, we explored
whether Fmnl3 and its homologous isoforms, Fmnl2a and
Fmnl2b, are involved in CVP formation. In situ hybridization an-
alyses revealed fmnl3 mRNA to be exclusively expressed in
vascular ECs, while fmnl2a and fmnl2b mRNAs were broadly
expressed in zebrafish embryos (Figure S5B). RT-PCR analyses
of GFP-positive ECs isolated from Tg(fli1:GFP) embryos sug-
gested predominantly fmnl3, but, weakly, other formin-like pro-
teins such as fmnl1, fmnl2a, and fmnl2b, to be expressed by
the ECs in zebrafish embryos (Figure S5C). Furthermore, CVP
formation was significantly inhibited by knocking down Fmnl3
but not by knockdown of Fmnl2a or Fmnl2b (Figures 5E and
5F; Figures S5D–S5I). Defective CVP formation observed in
fmnl3 morphants was normalized by injecting MO-resistant
fmnl3 mRNA (Figures 5E and 5F), indicating the essential role
of Fmnl3 in CVP formation. Moreover, we investigated the
cause of the CVP defects observed in fmnl3 morphants. The
number of ECs in the CVP of fmnl3 morphants was not different
from that in the CVP of control MO-injected embryos, indicating
that Fmnl3 is not required for EC proliferation and survival dur-
ing CVP formation (Figures S5J and S5K). However, the ECs
failed to produce filopodia and sprout from the CV primordia
in fmnl3 morphants (Figures 5G–5I; Movie S6). Furthermore,
ECs expressing a dominant-negative mutant of Fmnl3 (Fmnl3
I684A-GFP), in which the FH2 catalytic domain is mutated,
could not localize on the ventral side of the CVP, indicating
the requirement of Fmnl3 for ventral migration of ECs during
CVP formation (Figures 5J and 5K). Consistently, an in vitro
EC spheroid-sprouting assay also revealed the requirement of
Fmnl3 for EC sprouting (Figures S5L and S5M). In a Tg zebra-
fish line that expresses Fmnl3-GFP in ECs, Fmnl3-GFP waset in the GFP image is the single-scanmerged image of differential interference
re indicated on the right. Note that accumulation of GFP-N-WASP CRIB in the
mutant, which is incapable of binding GTP-boundCdc42 (GFP-N-WASPCRIB
ll bodies of ECs located at the vascular front in the CVP, as observed in (A), was
e shown as means ± SEM (n = 15).
bryos injected withUAS:mCherry,GFP-N-WASPCRIBH211D Tol2 plasmid are
e vascular front in the CVP, as observed in (C), is shown as in (B) (n = 13). Error
fli1:GFP) embryos injected with 5 ng control MO (upper panel), 5 ng cdc42MO
RNA (lower panel) are shown as in Figure 1G.
SEM (control MO, n = 6; cdc42MO, n = 5; cdc42MO + cdc42 mRNA, n = 5).
i1:Myr-GFP) embryos injected with 5 ng control MO (upper panels) and 5 ng
as quantified as in Figure 2B (control MO, n = 6; cdc42MO, n = 5). Error bars
(G), was quantified as in Figure 1D (controlMO, n = 10; cdc42MO, n = 11). Error
mCherry);(fli1:Myr-mCherry) embryos injected with UAS:GFP-Tol2 plasmid or
at the indicated time points. The merged images of GFP (green) and mCherry
ECs, respectively. Note thatMyr-GFP-ACK42-expressing ECs failed tomigrate
(flk1:Gal4FF-2A-mCherry);(fli1:Myr-mCherry) embryos injected with UAS:GFP
d in the dorsal part of the CVP (dCVP) or the ventral part of the CVP (vCVP), as
9).
no significance. See also Figure S3 and Movie S5.
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Figure 4. Arhgef9b, a Cdc42 GEF, Is
Involved in Bmp-Mediated CVP Formation
(A) Expression patterns of arhgef9b mRNA in
zebrafish embryos at 24 and 30 hpf as detected by
whole-mount in situ hybridization. The caudal
region is enlarged in the lower panel. A sense
probe was used to confirm the specificity of the
hybridization reaction. DA, dorsal aorta; CA,
caudal artery.
(B) Projection views are shown of confocal z
stack images of the caudal regions of 33 hpf
Tg(fli1:Myr-mCherry) embryos injected with 2.5 ng
control MO, 2.5 ng arhgef9b MO, and 2.5 ng
arhgef9b MO, together with either 100 pg MO-
resistant GFP-arhgef9b mRNA or 100 pg MO-
resistant GFP-arhgef9b 4AmRNA as in Figure 1G.
(C) The CVP width, as observed in (B), was quan-
tified as in Figure 1H (control MO, n = 13; arhgef9b
MO, n = 11; arhgef9b MO + GFP-arhgef9b WT
mRNA [WT], n = 14; and arhgef9b MO + GFP-
arhgef9b 4AmRNA [4A], n = 5). Error bars indicate
means ± SEM.
(D) 3D-rendered confocal images of the CVP of 29
hpf Tg(fli1:lifeact-mCherry);(fli1:Myr-GFP) embryos
injected with 5 ng control MO and 5 ng arhgef9b
MO are shown as in Figure 1A.
(E) The number of sprouts extending from the CV
primordia, as observed in (D), was quantified as in
Figure 2B (control MO, n = 8; arhgef9b MO, n = 7).
Error bars indicate means ± SEM.
(F) The number of filopodia for each EC located at
the vascular front, as observed in (D), was quanti-
fied as in Figure 1D (control MO, n = 8; arhgef9b
MO, n = 7). Error bars indicate means ± SEM.
(G) Projection view of confocal z stack images of
the caudal regions of 48 hpf Tg(fli1:GFP) embryos
injected with 2.5 ng control MO (upper panel) or
2.5 ng arhgef9b MO (lower panel), either alone
(Control) or together with hsp70l:bmp2b-FLAG
Tol2 plasmid. Dotted lines indicate ectopic venous
vessels.
(H) The areas covered by ectopic venous vessels,
as observed in (G), were quantified and expressed
as percentages relative to that observed in the
embryos injected with both control MO and
hsp70l:bmp2b-FLAG Tol2 plasmid. Data are
shown as means ± SEM (each sample, n = 12).
(I) Projection view of confocal z stack images of the
caudal regions of 33 hpf Tg(fli1:GFP) embryos in-
jected with control MO, both bmpr2a and bmp2rb
MOs, and arhgef9b MO, as indicated in the upper
left corner of each image, areshownas inFigure1G.
The amounts of injectedMOs (per embryo) are also
indicated in parentheses after the name of the MO.
(J) The CVP width, as observed in (I), was quantified as in Figure 1H (n R 5). Error bars indicate means ± SEM.
Scale bars, 100 mm in (B), (G), and (I). *p < 0.05; **p < 0.01; ***p < 0.001; n.s., no significance. See also Figure S4.localized in filopodia extending from ECs during CVP formation
(Figure 5L). Taken together, these results indicate that Fmnl3
regulates CVP formation by inducing EC extension, to form fi-
lopodia, and migration.
Fmnl3 Acts Downstream from the Bmp-Arhgef9b
Signaling Axis to Regulate CVP Formation
Next, we investigated whether the Bmp-Arhgef9b signaling axis
utilizes Fmnl3 to regulate CVP formation. Bmp2b-induced for-116 Developmental Cell 32, 109–122, January 12, 2015 ª2015 Elsevimation of ectopic venous vessels was suppressed by depletion
of Fmnl3 (Figures S6A and S6B). The embryos injected with
either a low dose of bmpr2a (1 ng)/bmpr2b (0.5 ng) MOs or a
low dose of fmnl3 MO (1 ng) exhibited normal CVP formation
(Figures S6C and S6D). However, coinjection of bothMOs signif-
icantly inhibited CVP formation, indicating a genetic interaction
between Bmp signaling and Fmnl3. Similarly, CVP formation
was not affected by the injection of either a low dose of arhgef9b
MO (1 ng) or a low dose of fmnl3 MO (1 ng) into zebrafisher Inc.
embryos but was significantly impeded by coinjection of both
MOs (Figures S6E and S6F). These findings suggest that
Fmnl3 acts downstream from the Bmp-Arhgef9b signaling
pathway to regulate CVP formation.
Cdc42 Promotes Fmnl3-Mediated Extension of EC
Filopodia during CVP Formation
Finally, we investigated how Cdc42 induces Fmnl3-mediated
extension of filopodia. Diaphanous-related formins (Drfs), a sub-
family of the formin proteins, are thought to be autoinhibited by
intramolecular interaction between their own N- and C-terminal
regions. Binding of active Rho GTPases to the N-terminal GBD
prevents this autoinhibitory intramolecular interaction to pro-
mote actin assembly (Watanabe and Higashida, 2004; Pollard,
2007; Higgs, 2005). Since Fmnl3 is a member of the Drf family
(Figure 6A), we hypothesized that Fmnl3 might be similarly auto-
inhibited in a manner dependent on an intramolecular interaction
between different regions of the same Drfs. The GFP-tagged
C-terminal region of Fmnl3 (Fmnl3 C-ter-GFP), but not the
GFP-tagged FH1-FH2 domain of Fmnl3 (Fmnl3 FH1/FH2-GFP),
was coimmunoprecipitated with the FLAG-tagged N-terminal re-
gion of Fmnl3 (Fmnl3 N-ter-FLAG) (Figure 6B). Furthermore,
either Fmnl3 C-ter-GFP or Fmnl3 FH1/FH2-GFP significantly
induced actin polymerization when overexpressed in human um-
bilical vein ECs (HUVECs), although GFP-tagged wild-type (WT)
Fmnl3 (Fmnl3 WT-GFP) had no effect on actin organization (Fig-
ures 6C and 6D). However, coexpression of Fmnl3 N-ter-FLAG
apparently blunted the actin polymerization induced by Fmnl3
C-ter-GFP but not that induced by Fmnl3 FH1/FH2-GFP (Figures
6C and 6D). In addition, actin assembly was promoted by the
Fmnl3 mutant lacking the C-terminal diaphanous autoregulatory
domain (DAD) (Fmnl3DDAD-GFP) (Figures 6C and 6D). These re-
sults indicate that the actin polymerization activity of Fmnl3 is
autoinhibited by the intramolecular interaction between the
N-terminal region and the C-terminal DAD.
Next, we explored whether autoinhibition of Fmnl3 is pre-
vented by Rho GTPases by examining the association of
Fmnl3 N-ter-FLAG containing GBD with Rho GTPases. The
active form of Cdc42, but not that of either RhoA or Rac1, bound
to the N-terminal region of Fmnl3 (Figure 7A). In addition, low-
level expression of the active form of Cdc42, although it did
not itself affect organization of the actin cytoskeleton, synergis-
tically induced actin polymerization with WT Fmnl3 (Figures 7B
and 7C). In contrast, neither RhoA nor Rac1 functioned with
Fmnl3-GFP to induce actin polymerization (Figures 7B and 7C).
Moreover, Fmnl3-GFP was broadly localized to the plasma
membrane when expressed in ECs, while coexpression of active
Cdc42 relocated Fmnl3-GFP in the filopodia (Figure S7A). These
results suggest Fmnl3 activity to be increased by binding of
Cdc42 to its own N-terminal region.
To confirm this observation, we constructed two plasmids
encoding the mutants of Fmnl3: the Fmnl3 I111D-GFP mutant,
which is incapable of binding to Cdc42 but retains the capacity
for the intramolecular interaction (Figures S7B and S7C), and
the Fmnl3 I684A-GFP mutant in which the FH2 catalytic domain
is mutated. Unlike WT Fmnl3, the Fmnl3 I111D-GFP and Fmnl3
I684A mutants did not induce actin polymerization coopera-
tively with Cdc42 (Figures S7D–S7G). Moreover, CVP defects
caused by Fmnl3 deficiency were normalized by expressionDevelopmof WT Fmnl3 but not by that of either the Fmnl3 I111D mutant
or the Fmnl3 I684A mutant (Figures 7D and 7E; Figures S7H–
S7K). Collectively, these findings indicate that Cdc42 induces
the Fmnl3-deriven assembly of EC filopodia through its binding
to the N-terminal region of Fmnl3, thereby promoting CVP
formation.
DISCUSSION
During sprouting angiogenesis, ECs located at the front of
growing vessels actively extend filopodia in the direction of cell
migration in response to guidance cues. Our present results
demonstrate a crucial role for Cdc42-mediated formation of
EC filopodia in sprouting angiogenesis during CVP formation
and further delineate the signaling pathways that act upstream
and downstream from Cdc42 by exploiting in vivo fluores-
cence-based bioimaging techniques. Cdc42 is activated by
Bmp through Arhgef9b and promotes EC migration by inducing
Fmnl3-mediated formation of EC filopodia, thereby facilitating
sprouting angiogenesis during CVP formation.
Bmp-induced extension of EC filopodia may not be involved in
EC guidance during angiogenic sprouting of CVP. Filopodia are
believed to act as antennae that can sense gradients of guidance
cues during directional cell migration. It has also been reported
that filopodia extending from endothelial tip cells lead the way
by sensing a VEGF gradient during angiogenic sprouting in the
early postnatal retina (Gerhardt et al., 2003). In this study, we
found that Hsp-mediated ubiquitous expression of Bmp2b did
not impair angiogenic sprouting of CVP, although the formation
of ectopic venous vessels was induced. Furthermore, Bmp2b,
an angiogenic factor responsible for CVP formation, is ex-
pressed not only in the tissues surrounding the CVP but also in
CV primordia, indicating that there is no Bmp gradient (Wiley
et al., 2011). These results suggest that Bmp does not function
as a guidance cue but rather may instead increase the motility
of ECs during CVP formation. Thus, other factors, such as the
extracellular matrix or repulsive guidance cues, might regulate
directional EC migration during CVP formation.
Actin polymerization may regulate Bmp-induced EC migra-
tion in different ways. Lat. A not only disrupted filopodia but
also inhibited EC migration during CVP formation, suggesting
that extension of filopodia is required for EC migration during
CVP formation. However, inhibition of actin polymerization by
Lat. A not only blocks the extension of filopodia but also af-
fects the actomyosin-mediated force generation that is also
required for cell movement as well. Therefore, Lat. A might
also affect EC migration independently of the disruption of
EC filopodia. Thus, detailed examinations are required to eluci-
date the role of actin polymerization in EC migration during
CVP formation.
The extension of filopodia is involved in Bmp-induced EC
migration during CVP formation, but it is not required for
VEGF-mediated EC migration during intersegmental vessel
(ISV) formation. Both filopodia and lamellipodia provide sites
for adhesive contacts at the leading edge of migrating cells,
thereby promoting cell migration (De Smet et al., 2009; Mattila
and Lappalainen, 2008; Mellor, 2010). During VEGF-mediated
ISV formation, endothelial tip cells migrated by protruding lamel-
lipodia even when the formation of filopodia was selectivelyental Cell 32, 109–122, January 12, 2015 ª2015 Elsevier Inc. 117
Figure 5. Fmnl3 Is Required for EC to Extend into Filopodia during CVP Formation
(A) 3D-rendered confocal images of the CVP of 29 hpf Tg(fli1:lifeact-mCherry);(fli1:Myr-GFP) embryos treated with DMSOor 1 mMSMIFH2, a formin inhibitor, from
25 to 29 hpf are shown as in Figure 1A.
(B) The number of filopodia for each EC located at the vascular front, as observed in (A), was quantified as in Figure 1D (DMSO, n = 10; SMIFH2, n = 12).
(C) Projection view of confocal z stack images of the caudal regions of 33 hpf Tg(fli1:GFP) embryos treated with DMSO or SMIFH2 from 24 to 33 hpf are shown as
in Figure 1G.
(legend continued on next page)
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blocked (Phng et al., 2013). In clear contrast, ECs failed to induce
lamellipodial protrusion in the absence of filopodia, thereby lead-
ing to defective migration of ECs during Bmp-dependent CVP
formation. Thus, filopodia and lamellipodia differentially regulate
EC migration during angiogenic sprouting of CVP and ISV; filo-
podia are essential for Bmp-induced EC migration during CVP
formation, whereas VEGF promotes EC migration through the
formation of either filopodia or lamellipodia to regulate ISV devel-
opment. This difference might be attributable to the distinct
signaling pathways induced by Bmp and VEGF. Rac1 promotes
lamellipodial protrusion, while filopodial extension is induced by
Cdc42. Therefore, Bmp might be unable to induce lamellipodial
protrusion and EC migration in the absence of filopodia because
of its inability to activate Rac1. In contrast, since VEGF can
activate both Cdc42 and Rac1, the promotion of EC migration
during ISV formation by lamellipodial protrusion may have
been possible even in the absence of filopodia. However, further
studies are needed to confirm this hypothesis.
Our present data showed that Arghef9b is a Cdc42 GEF that
mediates Bmp-induced angiogenesis during CVP formation in
zebrafish. However, a role of Arhgef9 in vascular development
has not been reported in mammals, although it is known to regu-
late GABAergic neurotransmission (Harvey et al., 2004; Kins
et al., 2000). Indeed, Arhgef9-deficient mice displayed deficits
in spatial learning and increased anxiety-like behavior, but the
formation of vascular structures was normal (Papadopoulos
et al., 2007). Thus, Cdc42 GEFs other than Arhgef9 might be
involved in Bmp-induced angiogenesis in mammals.
Fmnl3 induces EC filopodial extension, acting downstream
from Cdc42, to regulate CVP formation. Consistently, the FH1-
FH2 domain of FMNL3, when overexpressed, is known to pro-
mote filopodial formation in multiple cell lines (Harris et al., 2010;
Thompson et al., 2013). FMNL3 and its homologs, FMNL1 and
FMNL2, constitute a subfamily of Drfs. The Drfs are thought to
be held in an autoinhibited state through an intramolecular inter-
action between their own N- and C-terminal regions (Watanabe
and Higashida, 2004; Pollard, 2007; Higgs, 2005). Binding of
Rho family GTPases to the N-terminal GBD prevents this autoin-
hibitory interaction, thereby enabling the FH2 catalytic domain
to induce actin polymerization. Consistently, our in vitro analyses(D) The CVP width, as observed in (C), was quantified as in Figure 1H (DMSO, n
(E) Projection view of confocal z stack images of the caudal regions of 33 hpf Tg(fli
(middle panel), and 2.5 ng fmnl3 MO together with 100 pg MO-resistant fmnl3 m
(F) The CVP width, as observed in (E), was quantified as in Figure 1H (control MO
means ± SEM.
(G) 3D-rendered confocal images of the CVP of 28 hpf Tg(fli1:lifeact-mCherry);(fl
their subsequent time-lapse images at the indicated time points. The ratio image
(H) The number of sprouts extending from the CV primordia, as observed in (G),
indicate means ± SEM.
(I) The number of filopodia for each EC located at the vascular front as observed
bars indicate means ± SEM.
(J) Projection views of confocal z stack images of the caudal regions of 33 hpf T
(UAS:GFP) or UAS:fmnl3 I684A-GFP Tol2 plasmid (UAS:fmnl3 I684A-GFP) are s
(K) Percentages of GFP-expressing ECs localizing in the dorsal part of CVP (dCVP
(UAS:GFP, n = 3; UAS:fmnl3 I684A-GFP, n = 3). Error bars indicate means ± SE
(L) Projection view of confocal z stack images of one of the ECs located at
GFP);(fli1:Myr-mCherry) embryo at 29 hpf. GFP (Fmnl3-GFP) and mCherry image
area on the merged image is enlarged on the right.
Scale bars, 100 mm in (C) and (E), 50 mm in (J), and 20 mm in (L). **p < 0.01; ***p
Developmrevealed that Fmnl3 activity is autoinhibited by an intramolecular
interaction between its N-terminal region and the C-terminal
DAD and that activation of Fmnl3 is achieved by binding of
GTP-loaded Cdc42 to its N-terminal region.
Fmnl3 is required for the angiogenic sprouting of CVP, but it is
not essential for that of ISVs. It was previously reported that
depletion of Fmnl3 leads to impaired formation of ISVs in zebra-
fish (Hetheridge et al., 2012). However, we did not observe
obvious defects in ISVs in fmnl3morphants, although ISV forma-
tion appeared to be delayed by Fmnl3 knockdown. Thus, Fmnl3
might be involved in ISV formation, but it is not essential for
angiogenic sprouting of ISVs. Phng et al. (2013) recently reported
that filopodia are not essential for sprouting angiogenesis during
ISV formation, although they are required for efficient EC migra-
tion. In clear contrast, the present study revealed filopodia to be
indispensable for not only ECmigration but also sprouting angio-
genesis during CVP formation. Since Fmnl3 is involved in the for-
mation of filopodia, whether Fmnl3 is necessary for sprouting
angiogenesismay depend onwhether or not filopodia are essen-
tial for EC migration during angiogenesis. If so, Fmnl3 might not
be required for angiogenic sprouting of ISVs, because filopodia
are not essential for EC migration during ISV formation.
In conclusion, the present results indicate that Bmp activates
Cdc42 through Arhgef9b, which promotes sprouting angiogen-
esis during CVP formation by inducing Fmnl3-mediated exten-
sion of EC filopodia.
EXPERIMENTAL PROCEDURES
Plasmids
The plasmids used in this study were constructed as described in the Supple-
mental Experimental Procedures.
Zebrafish and Transgenesis
Zebrafish (Danio rerio) were maintained as previously described (Kwon
et al., 2013). Animal experiments were approved by the animal committee
of the National Cerebral and Cardiovascular Center and performed in
accordance with the regulations of the National Cerebral and Cardiovascu-
lar Center.
Tg(fli1:Lifeact-mCherry), Tg(fli1:Myr-GFP), Tg(flk1:NLS-Eos),Tg(flk1:mCherry-
CAAX), Tg(flk1:Gal4FF-2A-mCherry), Tg(UAS:RaichuEV-Cdc42), Tg(UAS:
RaichuEV-Cdc42 NC), Tg(UAS:Myr-GFP-ACK42), and Tg(UAS:fmnl3-GFP)= 7; SMIFH2, n = 9). Error bars indicate means ± SEM.
1:GFP) embryos injected with 2.5 ng control MO (upper panel), 2.5 ng fmnl3MO
RNA (lower panel) are shown as in Figure 1G.
, n = 8; fmnl3 MO, n = 6; fmnl3 MO + fmnl3 mRNA, n = 8). Error bars indicate
i1:Myr-GFP) embryos injected with 2.5 ng control MO or 2.5 ng fmnl3 MO and
s of mCherry/GFP are shown as in Figure 1A.
was quantified as in Figure 2B (control MO, n = 8; fmnl3 MO, n = 8). Error bars
in (G) was quantified as in Figure 1D (control MO, n = 8; fmnl3MO, n = 8). Error
g(fli1:Gal4FF);(fli1:Myr-mCherry) embryos injected with UAS:GFP Tol2 vector
hown as in Figure 2D.
) or the ventral part of CVP (vCVP), as observed in (J), are shown asmean ± SEM
M.
the vascular front of the CVP in a Tg(flk1:Gal4FF-2A-mCherry);(UAS:fmnl3-
s and the merged image (Merge) are shown as indicated at the top. The boxed
< 0.001. See also Figure S5 and Movie S6.
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Figure 6. Actin Polymerization Activity of
Fmnl3 Is Autoinhibited by Intramolecular
Interaction between Its N-Terminal and
C-Terminal Regions
(A) Schematic illustrations of Fmnl3 and its
mutants. DID, diaphanous inhibitory domain; DD,
dimerization domain; ter, terminus.
(B) 293T cells were transfected without () or with
(+) the plasmid encoding Fmnl3 N-ter-FLAG
together with either the plasmid expressing Fmnl3
C-ter-GFP or that encoding Fmnl3 FH1/FH2-GFP
as indicated at the top. Immunoprecipitates (IP:
FLAG) of cell lysates and total cell lysate (TCL) al-
iquots were subjected to western blot (WB) ana-
lyses with anti-GFP and anti-FLAG antibodies as
indicated on the left.
(C) HUVECs transfectedwith the plasmid encoding
Myr-GFP (0.5 mg) or that encoding C-terminally
GFP-tagged Fmnl3 (0.5 mg) or its mutants (0.5 mg,
Fmnl3 C-ter-GFP, Fmnl3 FH1/FH2-GFP, and
Fmnl3 DDAD-GFP), as indicated at the top,
together with the empty vector (1 mg, Vector) or the
plasmid expressing C-terminally FLAG-tagged
Fmnl3 N-ter mutant (1 mg, Fmnl3 N-ter-FLAG), as
indicated on the left, were stained with rhodamine-
phalloidin. The rhodamine (F-actin) and GFP im-
ages are shown. Arrows indicate GFP signal-pos-
itive cells. Scale bars, 30 mm. Note that expression
of either Fmnl3 C-ter-GFP or Fmnl3 FH1/FH2-GFP
induced stress fiber formation, while thin actin fi-
bers were formed throughout the cell in response
to expression of Fmnl3 DDAD-GFP.
(D) Total cellular F-actin levels as observed in (C)
were quantified by measuring the rhodamine
fluorescence intensity of individual cells and ex-
pressed as percentages relative to that observed
in Myr-GFP-expressing cells. Data are shown
as means ± SEM (n = 17). *p < 0.05; n.s., no
significance.
See also Figure S6.zebrafish lines were generated as described in the Supplemental Exper-
imental Procedures.
Image Acquisition, Processing, and Quantification
The zebrafish embryos were mounted in 1% low-melting agarose poured on a
35-mm-diameter glass-base dish (Asahi Techno Glass), as previously
described (Kwon et al., 2013). Confocal images were taken with a FluoView
FV1000 confocal upright microscope system (Olympus) with water-immersion
203 (XLUMPlanFL, 1.0 NA) and 403 (LUMPlanFL, 0.80 NA) lenses and equip-
pedwith amulti-alkali or aGaAsP photomultiplier tube regulatedwith FluoView
ASW software (Olympus). The 440 nm, 473 nm, and 559 nm laser lines were
used. For confocal time-lapse imaging, images were collected every 15 min
for 5–10 hr. To avoid cross-detection of green and red signals, images were
acquired sequentially at 473 nm and 559 nm. Image files were processed
and analyzed using Volocity software (PerkinElmer).
To visualize the localization of F-actin in ECs, mCherry and GFP fluores-
cence images in the Tg(fli1:Lifecat-mCherry);(fli1:Myr-GFP) embryos were ac-
quired. After background subtraction, the mCherry/GFP ratio images were
created by Volocity software and displayed as intensity-modulated display
(IMD) images.
Similarly, localization of GTP-bound Cdc42 in ECs was visualized by
collecting mCherry and GFP images in Tg(fli1:Gal4FF) embryos injected120 Developmental Cell 32, 109–122, January 12, 2015 ª2015 Elseviwith a UAS:mCherry,GFP-N-WASP CRIB Tol2 plasmid. After background
subtraction, the GFP/mCherry ratio images were created and displayed
as IMD images. To quantify the levels of GTP-bound Cdc42 in the filopodia
and cell bodies of ECs at the vascular front, a region of interest (ROI) en-
compassing one filopodium that ventrally extended from the leading edge
and a 2-mm-diameter circular ROI drawn in the vicinity of the nucleus of
the leading-edge side were used, respectively. The mean emission ratio
of GFP/mCherry, calculated by dividing the fluorescence intensity of
GFP by that of mCherry in each ROI, was scored as the amount of
GTP-Cdc42.
Quantitative image analysis was performed as described in the Supple-
mental Experimental Procedures.
Heat Shock and Chemical Treatment
To ubiquitously express Noggin3-FLAG and Bmp2b-FLAG, Tg(fli1:Lifeact-
mCherry);(fli1:Myr-GFP) or Tg(fli1:GFP) embryos were injected with
25 ng pTol2-cmlc2:NLS-mCherry-HS4-hsp70l:noggin3-FLAG (hsp70l:nog-
gin3-FLAG) and 25 ng pTol2-cmlc2:NLS-mCherry-HS4-hsp70l:bmp2b-FLAG
(hsp70l:bmp2b-FLAG) plasmid along with Tol2 transpopase RNA (25 ng),
and were heat shocked at 22 hpf for 2 hr and at 24 hpf for 30 min at 39C,
respectively. The embryos carrying the corresponding genes were selected
by the expression of mCherry in the nucleus of cardiac myocytes.er Inc.
Figure 7. Cdc42 Activates Fmnl3 to Regulate CVP Formation
(A) 293T cells transfected with the plasmid encoding eitherMyr-GFP orC-terminally GFP-tagged Fmnl3 N-termutant (Fmnl3 N-ter-GFP) together with the plasmid
encoding FLAG-tagged constitutive active or dominant-negative mutants of Rho GTPases, as indicated at the top, were subjected to coimmunoprecipitation
analysis as in Figure 6B. IP, immunoprecipitate; WB, western blot; TCL, total cell lysate.
(B) HUVECs transfected with the plasmid encoding mCherry (1 mg) or that encoding C-terminally FLAG-tagged Fmnl3 (Fmnl3-FLAG, 1 mg) together with empty
vector (0.1 mg) or the plasmid expressing RhoA Q63L (0.1 mg), Rac1 G12V (0.1 mg), or Cdc42 Q61L (0.1 mg) were immunostained with anti-FLAG antibody (FLAG)
and stained with phalloidin labeled with Alexa Fluor 488 (F-actin). Note that coexpression of Fmnl3-FLAG and Cdc42 Q61L induced the formation of thin actin
fibers throughout the cells. Arrows indicate mCherry signal- or FLAG signal-positive cells.
(C) Total cellular F-actin levels, as observed in (B) were quantified as in Figure 6D. Data are expressed as percentages relative to that observed in the cells
transfected with empty vector and mCherry-expressing plasmid, and shown as mean ± SEM (n = 16).
(D) Projection view of confocal z stack images of the caudal regions of 33 hpf Tg(fli1:GFP) embryos injected with control MO or fmnl3MO together with the vehicle
or MO-resistant mRNA encoding WT Fmnl3 or Fmnl3 I111D are shown as in Figure 1G.
(E) The CVP width, as observed in (D), was quantified as in Figure 1H (nR 4). Error bars indicate means ± SEM.
Scale bars, 30 mm in (B) and 100 mm in (D). *p < 0.05; **p < 0.01; n.s., no significance. See also Figure S7.Tg(fli1:Lifeact-mCherry);(fli1:Myr-GFP), Tg(flk1:NLS-Eos);(fli1:Myr-mCherry),
and Tg(fli1:GFP) embryos were dechorinated and incubated in the E3 medium
containing 0.1 mM Lat. A and 1 mM SMIFH2 for 23–33 hpf or 25–30 hpf as
described in the legends for Figures 1 and 5. As a control, the embryos were
also incubated in the E3 medium containing DMSO.
Whole-Mount In Situ Hybridization
Whole-mount in situ hybridization for zebrafish embryos was carried out
according to standard procedures as described in the Supplemental Experi-
mental Procedures.DevelopmImmunocytochemistry
HUVECs grown in a 35-mm glass-based dish (Asahi Techno Glass) coated
with Cellmatrix Type I-C (Nitta Gelatin) were transfected with plasmids, as
described in the legends for Figures 6, 7, and S7, and were subjected to immu-
nocytochemistry as described previously (Ando et al., 2013; Fukuhara et al.,
2008).
Statistical Analysis
Data were analyzed using GraphPad Prism software (GraphPad Software) and
expressed asmeans ± SEM. Statistical significance for paired samples and forental Cell 32, 109–122, January 12, 2015 ª2015 Elsevier Inc. 121
multiple comparisons was determined using Student’s t test and one-way
ANOVA with Tukey’s test, respectively. Data were considered statistically sig-
nificant at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and six movies and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2014.11.024.
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